Publication Date:
2016-01-22
Description:
Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms Cell Death and Disease 7, e2063 (January 2016). doi:10.1038/cddis.2015.328 Authors: L Wang, H Li, Y Ren, S Zou, W Fang, X Jiang, L Jia, M Li, X Liu, X Yuan, G Chen, J Yang & C Wu
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink